ARCHIVES

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Shubik Named To Another NCA Term In Surprise Move

June 25, 1976

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

NCI Clarifies Plan For Review Of Epidemiologic Research

June 1, 2001

DeVita To continue Discussions On Expanded Chops Despite ACCC Coolness; Would Go To DRCCA Board

March 27, 1981

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014